https://www.selleckchem.com/pr....oducts/SB-203580.htm
Given the pathological complexity of the said disease, nanotechnology-based approaches are more enticing as it comes with added advantage of site-specific drug delivery with higher bioavailability and reduced dosage regimen. In the present review article, we have made an attempt to explore the pathophysiology of type II DM, the conventional treatment approaches (mono and combination therapy) as well as the nano based drug delivery approaches for the treatment of type II DM.Long non-coding RNAs (lncRNAs) play important roles in many ph
Like
Comment
Share
